The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Given the rise so far, if/when Tunisia comes in strong I'd say 1.5-1.75p is achievable within 2 weeks
Considering this has had heavy 1m block selling so far today its definitely holding very strong. About £70k sold in 7 trades.
The $5.7m will substantially derisk this when it comes.
A bit to catch up. I think many took it off its peak there to buy on uk markets. Which in turn brings the arbitrage opportunity down
Earlier I did a FoK 35% higher than sp just to get it in. Always a gamble incase it spikes just to be spiteful! But I'd say buying below say 1.3 is a safe bet over the next couple of weeks
I took one for the team 0.90 there you go lads
Its flat because its nt to buy
Wait for the jump
This will definitely hit 1p today
I think we should have a continued run from the news on the 23rd
https://live.euronext.com/en/product/equities/CA98936C1068-MERK/overview
This is going to gap up big tomorrow
Thanks Mr Neil for prompting this to occur.
I am reassured that things are still progressing.... for now
Respect mr Neil for prompting this to occur.
It does not tell us anything new, but I am reassured for now that things are still progressing
Because he is the only one consulting a corporate solicitor stimpy ;). Tends to get things moving.
Cheers Neil I think *any* news is something, if the timeline is as you suggest it would be great
You should check out the SPACs that have been going on all year on the nasdaq. They have more like 50m cash and valued 500m to 1bn prior to merger. Typically keeping around 20% of the new company on merger.
Such valuations of 5m have not been unusual at all in the successful few this last couple of years. It depends on the quality of the management team, what they can fight for, and how quickly they can achieve it.
Neilin, or anyone else who is making progress contacting them.
Can you get the to clarify one thing. Can they list in all detail the names of the regulations that they are stuck on, and the sub-points etc.
This in no way jeopardises anything.
@Ivan's many of those that have successfully rto from cash shell are valued 3-5m on 500k cash.
Still plenty of room here.
My honest gut feeling here is that there is no target, and no progress has been made on anything in the last year. But they know the legal/ professional damage will follow them around the rest of their careers so are just delaying admitting they completely failed.
The way I see it, shareholders have a right to know two basic things. 1. Are the bod actually currently pushing through *one* specific opportunity?? 2. What is a realistic very basic deadline target to achieve the regulatory requirements?
They have to answer the first one at the very least.
The second one they've failed us so long we won't hang them for failing a deadline but i don't see the harm to anyone in saying q1 2021 etc
Not that I would attend, and I am not a holder over 5%. But is there is another way? I think action groups can publish an Rns like a circular right?
A well written open letter to shareholders would immediately prompt a comprehensive reply from the bod I think.